G827-0218 Screening compound: 3-(3,5-dimethyl-1-{3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H-pyrazol-4-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

G827-0218 Screening compound: 3-(3,5-dimethyl-1-{3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H-pyrazol-4-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide
G827-0218 Screening compound: 3-(3,5-dimethyl-1-{3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H-pyrazol-4-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G827-0218
3-(3,5-dimethyl-1-{3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H-pyrazol-4-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G827-0218

Molecular Formula

C20H28N8O2 (C20 H28 N8 O2)

Compound Name

3-(3,5-dimethyl-1-{3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H-pyrazol-4-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

IUPAC name

3-(35-dimethyl-1-{3-methyl-[124]triazolo[43-b]pyridazin-6-yl}-1H-pyrazol-4-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

SMILES

Cc1c(CCC(NCCN2CCOCC2)=O)c(C)nn1-c(cc1)nn2c1nnc2C

InChI

InChI=1S/C20H28N8O2/c1-14-17(4-7-20(29)21-8-9-26-10-12-30-13-11-26)15(2)27(24-14)19-6-5-18-23-22-16(3)28(18)25-19/h5-6H,4,7-13H2,1-3H3,(H,21,29)

InChI Key

AWYOJTNXSWFHFK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27163689

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

412.5

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

-0.658

Distribution Coefficient, logD

-0.733

Water Solubility, LogSw

-1.53

Polar Surface Area

83.260

Acid Dissociation Constant (pKa)

13.66

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

55.00

G827-0218 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antifungal Library (16415 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Agro:
  • Agro
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G827-0218 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G827-0218?
Check Price and Availability of G827-0218, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G827-0218 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G827-0218
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G827-0218
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G827-0218 available by request